In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 4, 2010, Pages

  Henry, Amanda ^a   Kennedy, Debra ^a   Lowe, Sandra ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL; SALMETEROL; TERBUTALINE; ADRENERGIC RECEPTOR STIMULATING AGENT;

AEROSOL; ASTHMA; AUTISM; BEHAVIOR; DISEASE ASSOCIATION; DRUG EXPOSURE; HEART ATRIUM FLUTTER; HUMAN; LANGUAGE; LETTER; NEUROPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; TOCOLYSIS; CHEMICALLY INDUCED; CHILD; FEMALE; PRENATAL EXPOSURE;

ADRENERGIC AGONISTS; ASTHMA; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 77957355140     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.04.025     Document Type: Letter

References (4)

1. F.R. Witter, A.W. Zimmerman, J.P. Reichmann, and S.L. Connors In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes Am J Obstet Gynecol 201 2009 553 559
2. M.T. Stein, S. Parker, J. Coplan, and H. Feldman Expressive language delay in a toddler J Dev Behav Pediatr 107 2001 905 909
3. J.D. Thrasher, K.Y. Kilburn, and I.B. Immers Autism, terbutaline and neurological impairment: Ramazzi Days 2007: 25th Anniversary Jubilee, Capri, Italy CR online journal www.collegiumramazzini.org Accessed March 11, 2010
4. L.A. Croen, J.K. Grether, C.K. Yoshida, R. Odouli, and J. Van de Water Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study Arch Pediatr Adolesc Med 159 2005 151 157